Endpoints for Validation of Tumour Markers for Recurrence Risk - Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581

被引：0
|
作者：
Mahmoud, N. N. [1 ]
Lopatin, M. [2 ]
Clark-Langone, K. [2 ]
Lee, M. [2 ]
Niedzwiecki, D. [3 ]
Venook, A. P. [4 ]
机构：
[1] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA
[2] Genom Hlth Inc, Med Oncol, Redwood City, CA USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70904-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [1] American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance).
    Van Blarigan, Erin
    Fuchs, Charles S.
    Niedzwiecki, Donna
    Ye, Xing
    Zhang, Sui
    Song, Mingyang
    Saltz, Leonard
    Mayer, Robert J.
    Mowat, Rex B.
    Whittom, Renaud
    Hantel, Alexander
    Benson, Al Bowen
    Atienza, Daniel M.
    Messino, Michael J.
    Kindler, Hedy L.
    Venook, Alan P.
    Ogino, Shuji
    Willett, Walter C.
    Giovannucci, Edward L.
    Meyerhardt, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Prognostic factors for overall survival, recurrence-free survival, and metastasis-free survival of colon cancer in Morocco
    El Agy, Fatima
    Chbani, Laila
    CANCER RESEARCH, 2023, 83 (07)
  • [3] OVERALL SURVIVAL, DISEASE-FREE SURVIVAL, AND RECURRENCE-FREE SURVIVAL FOR ENDOSCOPIC SUBMUCOSAL DISSECTION VERSUS GASTERECTOMY FOR EARLY GASTRIC CANCER, A METAANALYSIS
    Abdelfatah, Mohamed M.
    Barakat, Mohamed
    Ahmed, Yahya
    Othman, Mohamed O.
    GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB175 - AB176
  • [4] Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).
    Sweeney, Christopher
    Xie, Wanling
    Regan, Meredith M.
    Nakabayashi, Mari
    Buyse, Marc E.
    Clarke, Noel W.
    Collette, Laurence
    Dignam, James J.
    Fizazi, Karim
    Habibian, Muriel
    Halabi, Susan
    Kantoff, Philip W.
    Parulekar, Wendy R.
    Sandler, Howard M.
    Sartor, Oliver
    Soule, Howard R.
    Sydes, Matthew Robert
    Tombal, Bertrand F.
    Williams, Scott G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Postoperative Complications Compromised Disease-Free and Recurrence-Free Survival in CALGB 140503 Trial Patients
    Miller, D. L.
    Wang, X.
    Damman, B.
    Mentlick, J.
    Landreneau, R.
    Wigle, D.
    Jones, D.
    Conti, M.
    Ashrafi, A.
    Liberman, M.
    Port, J.
    de Perrot, M.
    Mitchell, J.
    Keenan, R.
    Bauer, T.
    Stinchcombe, T.
    Altorki, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S64 - S65
  • [6] Net survival in recurrence-free colon cancer patients
    Drouillard, Antoine
    Bouvier, Anne-Marie
    Boussari, Olayide
    Romain, Gaelle
    Manfredi, Sylvain
    Lepage, Come
    Faivre, Jean
    Jooste, Valerie
    CANCER EPIDEMIOLOGY, 2019, 61 : 124 - 128
  • [7] Survival after breast cancer recurrence: Effect of the disease-free interval
    Witteveen, A.
    Kwast, A. B. G.
    Sonke, G. S.
    IJzerman, M. J.
    Siesling, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S71 - S71
  • [8] High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer
    Zhou, Xin
    Shang, Yan-Na
    Lu, Ran
    Fan, Chuan-Wen
    Mo, Xian-Ming
    FUTURE ONCOLOGY, 2019, 15 (18) : 2093 - 2106
  • [9] Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance).
    Van Blarigan, Erin
    Fuchs, Charles S.
    Niedzwiecki, Donna
    Ye, Xing
    Zhang, Sui
    Song, Mingyang
    Saltz, Leonard
    Mayer, Robert J.
    Mowat, Rex B.
    Whittom, Renaud
    Hantel, Alexander
    Benson, Al Bowen
    Atienza, Daniel M.
    Messino, Michael J.
    Kindler, Hedy L.
    Venook, Alan P.
    Ogino, Shuji
    Willett, Walter C.
    Giovannucci, Edward L.
    Meyerhardt, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival
    Rendleman, Justin
    Shang, Shulian
    Shields, Jerry
    Adaniel, Christina
    Fleming, Nathaniel H.
    Shapiro, Richard
    Berman, Russell S.
    Pavlick, Anna C.
    Shao, Yongzhao
    Osman, Iman
    Kirchhoff, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345